Who owns Bufferin (United States)?
Bufferin (United States) is owned by Genomma Lab (Mexico, BMV: LAB), which has owned the brand since 2018.[1]
This ownership is reported in official statements but has not yet been matched to a regulatory filing.
Evidence: Genomma Lab Internacional — Reporte Anual 2025 (Anexo N, BMV), Genomma Lab Internacional, S.A.B. de C.V. Last checked .
Key facts
- Current owner
- Genomma Lab Internacional, S.A.B. de C.V. reported
- Owned since
- Owner HQ
- 🇲🇽 Mexico, Mexico City
- Origin
- 🇺🇸 United States
- Category
- Consumer health › Over-the-counter medicine › Pain relief
- Parent ticker
- BMV: LAB
- Trademark registrant
- GENOMMA LAB USA, INC. (USPTO)
- Last verified
- · 2 sources
About Bufferin (United States)
Bufferin is a buffered aspirin sold for headaches and migraines. Genomma Lab USA bought the United States rights to it from Dr Reddy's Laboratories in June 2018, in one of two transactions that also brought it Cheracol D and Rose Milk, as part of a push into the American over-the-counter market. Genomma also sells Bufferin in Chile. The name is held by different owners in other countries.
Trademark record for Bufferin (United States)
The USPTO record for the Bufferin (United States) mark lists GENOMMA LAB USA, INC. as the owner of record (serial number 74334406). That name matches the owner named above.[2]
Ownership timeline of Bufferin (United States)
- 2018 – present Genomma Lab [1] reported
Where Bufferin (United States) sits in Genomma Lab
Controlling ownership as of . Brands grouped under the entity that owns them; large groups are collapsed.
Open the full Genomma Lab ownership tree →
See the full Genomma Lab brand portfolio (13) →
Other brands owned by Genomma Lab
Genomma Lab controls 13 brands on Brandtree, 6 of them in consumer health.
Also in consumer health
Other brands in pain relief, and who owns them
The 37 brands in pain relief on Brandtree belong to 21 owners. The largest is Haleon, with 3; Genomma Lab has 2.
| Brand | Owner | Owner based in |
|---|---|---|
| Advil | Haleon | 🇬🇧 United Kingdom |
| Air Salonpas | Hisamitsu Pharmaceutical | 🇯🇵 Japan |
| Motrin | Kenvue | 🇺🇸 United States |
| Dafalgan | Taisho Pharmaceutical | 🇯🇵 Japan |
| Nicotex | Cipla | 🇮🇳 India |
| Mentho Plus | Emami | 🇮🇳 India |
| Doril | Hypera | 🇧🇷 Brazil |
| Daleron | Krka | 🇸🇮 Slovenia |
About the owner: Genomma Lab
Genomma Lab is a publicly listed company headquartered in Mexico City, Mexico, founded in 1996. Brandtree records 13 brands under its control, and it is listed as BMV: LAB.
Genomma Lab Internacional is a Mexican over-the-counter medicine and personal care company that began in 1996 as a direct-response advertiser making its own television infomercials, moved into developing products of its own from 1997, and floated on the Mexican stock exchange as LAB on 18 June 2008. It sells more than 50 active brands in Mexico and eighteen countries beyond it, and puts its share of the Mexican over-the-counter market at 5.9 per cent and of the personal care categories it competes in at 5.0 per cent. Much of the portfolio was bought rather than invented.
🇺🇸 Bufferin (United States) and other American brands
Brandtree records a controlling owner for 2,570 brands that began in the United States. 501 of them (19%) are now controlled by a company headquartered in another country, Bufferin (United States) among them.
- Advil — Haleon 🇬🇧
- Alka-Seltzer — Bayer 🇩🇪
- Band-Aid — Kenvue 🇺🇸
- Breathe Right — Prestige Consumer Healthcare 🇺🇸
- Doan's — Dr. Reddy's 🇮🇳
- First Response — Church & Dwight 🇺🇸
Frequently asked questions
Who is the parent company of Bufferin (United States)?
The parent company of Bufferin (United States) is Genomma Lab, a publicly listed company headquartered in Mexico.
Is Bufferin (United States) American or Mexican?
Bufferin (United States) originated in the United States, but it is owned today by Genomma Lab, which is headquartered in Mexico. So Bufferin (United States) is an American-origin brand under Mexican ownership.
Since when has Genomma Lab owned Bufferin (United States)?
Genomma Lab has owned Bufferin (United States) since 2018.
Is Bufferin (United States) still owned by Genomma Lab?
Yes. As of 28 September 2026, Bufferin (United States) is still owned by Genomma Lab. The ownership record was last checked against primary sources on that date.
Sources (2) & corrections
Last verified . Every ownership fact above is backed by one of these primary documents. Numbers in brackets in the text refer to this list.
- [1] Genomma Lab Internacional — Reporte Anual 2025 (Anexo N, BMV) — Genomma Lab Internacional, S.A.B. de C.V., Annual report; retrieved 23 September 2026.
- [2] USPTO: BUFFERIN, serial 74334406, registration 1785176 — United States Patent and Trademark Office, Trademark registry; retrieved 28 September 2026.
Report a correction Opens a pre-filled GitHub issue. See our corrections policy.